Carotid Body Tumor
Dr.Steve Ramsey, PhD MSc-(hon) in Med Ultrasound.RMSKS.
ACMDTT,RMSKS,ARDMS,CRGS,CRVS; Experienced , MSK, peads, small part, and vascular sonographer, Blogger. SPI and MSK online instructor . Καθηγητ?? Α’ βαθμ?δα? at Ιατρικ? Σχολ? - Aristotle University of Thessaloniki .
CAROTID BODY TUMOR
Saad Ismail Al Hashimi ( Steve ), Ph.D.
Medical sonographer at Shift Imaging, Grand Prairie –Alberta-Canada
Abstract
The carotid body is the largest collection of paraganglia in the head and neck and is
found on the medial aspect of the carotid bifurcation bilaterally. Carotid body tumors are rare neoplasm arising from the chemoreceptor cells of the carotid bulb.
This case of carotid body tumor in a 49-year-old male, from East Canada who was
working in Alberta , and who presented with painless, pulsatility, gradually progressive
lateral neck swelling as he mentioned the increased in size in 3 years time.
The diagnosis is suspected on the basis of history, clinical and radiological examination
findings, and a successful surgical excision of the tumor is performed.
This is a brief literature about carotid body tumors in terms of its clinical and imaging presentation, evaluation, and management.
Keywords: Carotid body tumor; Carotid space; Chemodectomas; Neck tumor;
Paraganglioma.
MRI T2, AND T1 at the carotid body tumor at bifurcation
Background
Paraganglioma of the head and neck are rare vascular tumors derived from the
paraganglia tissues originating from the neural crest. They are usually benign and
hypovascularized. Diagnosis is relatively easy in condition to consider it in evaluating every lateral neck mass. (1)
Methods
The author made a retrospective study of the records of 5 patients, 4 patients who
presented with carotid body tumors at a various clinics that I used to work for in Calgary- Alberta and one patient in Shift Imaging- Grand prairie Alberta, during the period between 2011 and 2021. Epidemiologic, etiologic, diagnostic, and therapeutic features were analyzed.
CT SCAN of the carotid body tumor at bifurcation
Results
The average age of our patients was 40.5 years (30–60 years), with female
predominance 3 females and 2 males. The author noted 3 cases of isolated carotid
locations, 1 case of multiple locations, and 1 case at the medial bifurcation segment. A slow-growing neck mass was the main clinical presentation. Other signs were mild
pain, lump feeling, dysphonia, dizziness, headache, and tinnitus. Physical examination showed, in most cases, a neck nontender mass with side to side mobility. 3 of the patients were overweight.
The ultrasound image of the carotid body tumor at the carotid bifurcation
Imaging techniques included 2-D –ultrasound Imaging, Doppler ultrasound, computed tomography (CT), and magnetic resonance. Imaging, Urinary analysis
Urinary analysis for metanephrine was carried out in 1 case. The clinical presentation and imaging results strongly suggested the diagnosis of carotid Paraganglioma in all 5 cases.
Treatment was surgical excision
in 4 cases associated with a preoperative embolization
in 1 case and a postoperative radiotherapy in 1 case. Pathology confirmed the
diagnosis, and a lymph node metastasis was suspected of malignity in 1 case. The
evolution was favorable in 4 patients.
The ultrasound image of the carotid body tumor at the carotid bifurcation is highly vascular
Conclusions
Carotid body tumor requires early diagnosis and an adequate multidisciplinary team.
The diagnosis must be considered in the case of any pulsatility cervical mass. Surgery is the treatment of choice despite its risks especially in large tumors. The therapeutic indication should, ideally, be set in a multidisciplinary consultation.
Symptoms
Many times, a carotid body tumor does not cause symptoms and is found by your
doctor during an exam. You may be able to feel the tumor, but it is not painful. (1, 2)
If the tumor becomes large, it can press on the nerves, blood vessels or organs around it. This may cause throat pain, hoarseness, a numb tongue or make it hard to swallow. (3, 4)
The ultrasound image of the carotid body tumor at the carotid bifurcation
Carotid body tumors are not usually cancerous. But, they can grow quickly and become large. Because of this, the best treatment is often surgery to remove the tumor. In rare cases, radiation therapy is used. (4, 5)
领英推荐
Transcatheter Embolization
A Transcatheter embolization is a procedure that reduces blood supply to the tumor. It is done two or three days before surgery. A catheter will be guided through your groin artery into the blood vessels that feed blood to the tumor. Then, medication and/or a blocking device, such as foam, plastic, metal coil, or glue is used to stop the blood flow to the tumor.(6)
Surgical Removal (Resection)
Most times (60% -70%), the tumor can be removed without the need to repair or remove part of the carotid artery. If the artery does need to be repaired, it may be fixed with a simple suture repair. Sometimes, a more complicated repair is needed, such as creating a patch over a hole made during the tumor removal or replacing a section of the artery with a bypass graft (using another blood vessel to create a new pathway for the blood to flow).(7)
The ultrasound image of the carotid body tumor at the carotid bifurcation
Risks of Treatment
Treatment for carotid body tumors is generally very safe with good outcomes. However, all surgery involves risks. One possible complication is stroke, but this is rare and happens in less than 2% of carotid body tumor removals. The risk is highest for patients who have large tumors and need to have vascular repair or replacement. (8)
If the tumor affects the nerves near the carotid artery, such as the vagus nerve, facial nerve or hypoglossal nerve that controls your tongue, part of the nerve may need to be removed.
The ultrasound image of the carotid body tumor at the carotid bifurcation
This can cause problems with the affected nerve(s). The risk of nerve problems is higher if the tumor is large, but the overall risk of permanent nerve damage is less than 5%. If the tumor is cancerous, there is a less than 5% chance it will spread to other areas of your body (metastatic disease). The risk of having another carotid body tumor after surgery is 5% to 10%. The rate of malignancy is reported to be 6–12.5% of all cases. The 7–9% of the cases is hereditary. None of our five cases were bilateral or hereditary. (9-10-11-12)
References:
1-Shamblin WR, ReMine WH, Sheps SG, et al. Carotid body tumor (Chemodectomas)
Clinic -pathologic analysis of ninety cases, AmJ Surg. 1971; 122:732–739.
Doi: 10.1016/0002-9610(71)90436-3.?
2-Zhang WC, Cheng JP, Li Q, et al. Clinical and pathological analysis of malignant
carotid body tumor: a report of nine cases. Acta, Otolaryngol 2009; 19: 106.?
3- .Davidovic L, Djukic V, Vasic D, Sindjelic R, Duvnjak S. Diagnosis and Treatment of
Carotid Body Paraganglioma: 21 Years of Experience at a Clinical Center of Serbia.
World J Surg Onc 2005; 3(1):10.Doi:10.1186/1477-7819-3-10?
4-Lee K, Oh Y, Noh H et al. Extra adrenal Paraganglioma of the Body: Imaging
Features. AJR Am J Roentgenol. 2006; 187 (2):492-504.doi:10.2214/ajr.05.0370?
5-Arya S, Rao V, and Juvekar S, Dcruz A. Carotid Body Tumors: Objective Criteria to
Predict the Shamblin Group on MR Imaging. AJNR Am J Neuroradiol. 2008;
29(7):1349-54.doi:10.3174/ajnr.a1092
6-Boulos, R., Kricheff, T., Chase, N.: Value of cerebral angiography in the embolization
treatment of cerebral arteriovenous malformations. Radiology 97 (1970), 65
7-LaMuraglia GM, Fabian RL, Brewster DC, et-al the current surgical management of
carotid body Paraganglioma- J Vasc Surg. 1992; 15:1038–1044 doi: 10.1016/0741-
5214(92)90461-G.?
8- Maxwell JG, Jones SW, Wilson E, Kotwall CA, Hall T, Hamann S, et al. Carotid body
tumor excisions: adverse outcomes of adding carotid endarterectomy. J Am Coll
Surg. 2004; 198:36–41
9- Sobol SM, Dailey JC. Familial multiple cervical Paraganglioma: report of a kindred
and review of the literature. Otolaryngol Head Neck Surg. 1990; 102:382–390.
10- Myers EN, Johnson JT. Neoplasm. In: Cummings, CW, Fredrickson JM, Harker LA,
Krause CJ, Schuller DE, editor. Otolaryngology, Head and Neck Surgery, St Louis;
Mosby Year Book; 1993 pp. 1590–1597?
11-Kyriakos M. Pathology of selected soft tissue tumors of the head and neck in
Thawley SE, Panje WR editor. Comprehensive Management of Head and Neck
Tumors Philadelphia PA W.B. Saunders; 1987 pp. 1261–1264
12- Maves MD. Vascular tumors of the head and neck In: Bailey BJ, Johnson JT, Kohut
RI, Pillsbury HC, Tardy ME, editor. Head and Neck Surgery,
Otolaryngology. Philadelphia JB Lippincott; 1993 pp. 1397–1409
13- Defraigne JO, Sakalihassan N, Antoine P, Thiry A, Limet R. Carotid
Chemodectomas. Experience with nine cases with reference to pre-operative
embolization and malignancy Acta Chir Belg. 1997; 97:220–228
14-Por YC, Lim DT, Teoh MK, Soo KC. Surgical management and outcome of carotid
body tumors. Ann Acad Med Singapore.2002; 31:141–144.?
15-Mall J, Saclarides T, Doolas A, Eibl-Eibestfeld B, first report of hepatic lobotomy for metastatic carotid body tumor J Cardiovas Surg. 2000; 41:759–761